In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Tyco to buy General Surgical for $104mm in stock

Executive Summary

Tyco is buying General Surgical Innovations (minimally invasive devices) for about $104mm in Tyco stock. GSI shareholders will get a fraction of Tyco common worth about $7.50 for each of their common shares, a (pr)8% premium to GSI's 10-day trailing average. The acquisition will be accounted for as a purchase.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies